ACME Holds Lead Auditor Certificate Awarding Ceremony, ISO 14001:2015, Environmental Management Systems (EMS) Date: 01-06-2021
ACME has a long record of accomplishment of environmental friendly business leadership. As a part of its commitment towards the compliance obligations that relates to its environmental aspects the company is relentlessly keeping its due effort for the capacity building and human resource development program with regards to the environmental requirements that an organization can use to enhance its environmental performance. Recently, Human Resource & Administration division facilitated two mega programs to train a group of cross-functional management staff who have been finally qualified as certified Lead Auditor of ISO 14001:2015 EMS.
Company strongly believes that this team will be putting their intellectual and technical thoughts in implementing ISO 14001:2015 environmental management system that is intended to be in practice by the organization to manage its environmental responsibilities in a systematic manner that contributes to the environmental pillar of sustainability.
ACME Observes International Women’s Day, 2021 in Tribute to All the Female Employees Date: 09-03-2021
ACME, countries one of the leading pharmaceutical manufacturing company, celebrated the International Women’s Day 2021 at their Corporate Office as a tribute and gratitude towards all the female employees working in the company on Monday, 8th of March, 2021. The aim of this year’s theme, ‘Choose to Change’ for IWD 2021 was to encourage women empowerment in the challenging roles, titled as ‘ACME, Empowering Women in Leadership’.
Aligning with the global theme of IWD 2021, ACME celebrated the day with renowned media personality and model, Md. Adil Hossain Nobel, Chief Enterprise Business Officer of Robi Axiata Limited and famous female sports personality and Bangladeshi weightlifter, Mabia Akhter Simanta who won gold medal at the 2016 South Asian Games at Guwahati women’s in the 63 kg weight class, graced the program as special guests with their presence and shared their views. Alongside, Ms. Nagina Afzal Sinha, Chairman of The ACME Laboratories Ltd., Ms. Jahanara Mizan Sinha, Deputy Managing Director of The ACME Laboratories Ltd. & beloved wife of late Chairman Nasir-ur-Rahman Sinha were present in the ceremony as chief guests. The program was also enlightened with the presence of Mr. Rezaur Rahman Sinha, Ms. Sabrina Juned and Mr. Fahim Sinha, Directors of The ACME Laboratories Ltd. along with all the female employees working in the company’s corporate Office.
Notice of the 44th Annual General Meeting and Proxy Form of The ACME Laboratories Ltd. Date: 10-12-2020
ACME has launched THREE 1st time in Bangladesh products Date: 11-11-2020
The ACME Laboratories Ltd., a leading pharmaceutical company in Bangladesh is always focused on developing new products for our valued customers. Recently ACME has launched THREE new Products for the 1st Time in Bangladesh at a time. This is another step of ACME towards excellence. The new products are-
- Elago (Elagolix) Tab
Uses: For endometriosis pain
- Halotaz (Halobetasol Propionate & Tazarotene) Lotion
Uses: For plaque psoriasis
- Nystat Plus (Chlorhexidine Hydrochloride & Nystatin) Cream
Uses: For fungal and/or bacterial infections including ringworm, athlete’s foot, nappy rash etc.
Till now ACME’s total 1st time in Bangladesh Brands for this year is FIVE which covers different therapeutic class like- Hormone, Skin, Respiratory and CNS.
The ACME Laboratories Ltd. declared 25% cash dividend Date: 15-10-2020
This is for information of all concerned that the Board of Directors of The ACME Laboratories Ltd. in its 119th Meeting held on Wednesday, the 14 October 2020 during 3.30 p.m. to 5.30 p.m. through Digital Platform has approved the Audited Financial Statements and declared 25% cash dividend for the year ended on 30 June 2020.
Launching of Zolpidem tablet in the US Market Date: 14-10-2020
This is for information of all concerned that the Board of Directors of The ACME Laboratories Ltd. in its 119th Meeting held on 14 October 2020 during 3.30 p.m. to 5.30 p.m. through Digital Platform noted with immense pleasure, the launching of Zolpidem (5 mg. and 10mg.) tablet in the US Market through contract manufacturing.
It may be noted that exploring in the US Market has been one of the ACME’s most ambitious and dream projects which will generate yearly earnings of US$ 50,000.00 approximately.
Fight Against Covid- 19 Date: 06-04-2020
ACME Joins with DGDA to fight against Coronavirus by donating high quality PPE for healthcare professionals.
Leading pharmaceutical manufacturing company, ACME, has donated high quality personal protective equipment (PPE) to protect the health care professionals, serving the Covid-19 patients in the amid situation of coronavirus pandemic. On Sunday, on behalf of the company’s Management, Md. Ferdous Khan, Director Sales & Distribution, General Manager of Procurement Division, Mr. Sayed Hossain Patwary and Deputy General Manager of Marketing Division, Mohammad Ziauddin, handed over the first consignment of PPE which includes protective gowns, face masks, hand gloves etc. to the Directorate General of Drug Administration, Major General Md. Mahbubur Rahman.
Achievement of Excellence Award of ISO Practice Date: 20-01-2020
The ACME Laboratories Ltd. has achieved the Excellence Award of ISO certification body, TQCSI as the best client of the year 2019 in Bangladesh. This recognition is based on the best demonstration of excellence in management system development, its implementation and maintenance throughout the organization which was assessed during the external audits time to time.
Management congratulates all of the employees working at The ACME Laboratories Ltd. and expresses their heart felt facilitations for the wonderful work done which has helped the company achieving this remarkable recognition.
Management believes, this award is the result of concerted effort from every individual of all levels and a comprehensive adherence to the compliance guidelines, written procedures & SOPs and also strong commitment towards excellence.
Commencement of Commercial Production of Steroid and Hormone facility Date: 30-06-2019
The Board of Directors in its 104th Meeting held on 30 June 2019 at 3.30 p.m. at the Corporate Office of the Company, Court de la ACME, 1/4, Kallayanpur, Mirpur Road, Dhaka-1207 is pleased to declare the commencement of Commercial Production of its state-of-the-art Steroid and Hormone facility at Dhulivita, Dhamrai, Dhaka after successful completion of trail production.
It should be noted here that the last Annual General Meeting(AGM) of the Company, it was unanimously approved by the Shareholders that two projects out of three projects against which the fund was raised through Initial Public Offering (IPO) namely (1) Penicillin and (2) Steroid and Hormone projects will start commercial production within 30 June 2019. Accordingly, Penicillin project has already been started commercial production on 12 June 2019 for which necessary Price Sensitive Information (PSI) was published within the time limit. Now, the second project e.g. Steroid and Hormone project has been approved for commencement of commercial production.
Commencement of Commercial Production of Penicillin facility Date: 12-06-2019
The Board of Directors in its 103rd Meeting held on 12 June 2019 at 3.30 p.m. at the Corporate Office of the Company, Court de la ACME, 1/4, Kallayanpur, Mirpur Road, Dhaka-1207 is pleased to declare the commencement of Commercial Production of its state-of-the-art Penicillin facility at Dhulivita, Dhamrai, Dhaka after successful completion of trail production.
It should be noted here that the aforesaid Penicillin facility is one of the three projects against which the fund was raised through Initial Public Offering (IPO).